Table 2 List of topics within the areas of social, economic, and health impact of respiratory syncytial virus and corresponding references

[18],[20],[21],[23]-[26],[29],[31],[32],[43],[54],[55]

[23],[70],[75]

Impact on health

Respiratory infections

[21],[25]-[27],[29],[31],[32],[35],[36],[75],[84]

Wheezing and asthma

[20],[22],[28],[41]-[45],[51],[67],[75],[79],[83],[85]-[95],[105]

Allergic rhinoconjunctivitis

[41],[45],[79],[95]

Mortality

[18],[20],[22],[24],[46],[47],[49]-[51],[63],[67],[82]

Acute otitis media

[51]-[53]

Apneas

[31],[33],[67],[73]

Neurological involvement

[48],[73]

Cardiac involvement

[73]

COPD

[35]-[40]

Other

[28],[31],[41],[42],[45],[48],[51],[52],[56],[67],[73],[79],[84]

[20],[21],[41],[47],[70],[80],[103]

Impact on use of resources

Primary care visits

[20],[22],[34],[51]

Emergency room visits

[22],[34],[51]

Hospital visits

[22],[34],[41],[51]

Hospital admissions

[18],[20]-[26],[29],[30],[32],[34],[41],[46],[47],[49],[51],[54]-[56],[63],[65],[66],[77],[78],[80],[81],[96]-[101]

UCI admissions

[20]-[22],[24],[29],[32],[34],[41],[47],[48],[52],[56],[63],[65],[77],[78],[101]

Diagnostic tests

[21],[22],[30],[56]

Ventilation

[22],[24],[29],[31],[48],[49],[56],[63],[77],[78],[101]

Treatment

[22],[26],[30],[34],[74],[77],[102]

Impact on costs

Direct costs

[34],[41],[51],[55],[57]-[63],[70]

Indirect costs

[41],[59]-[63]

Strategies to reduce impact

Hygienic measures

[41],[49],[71],[104]

Prophylactic treatment

[19],[21],[34],[41],[46],[48],[49],[52],[55],[57]-[65],[69],[70],[72],[74],[76]-[78],[105],[106]

[21],[25],[26],[29],[30],[41],[47],[48],[58]-[60],[63],[64],[77],[80]

[22],[24],[35]-[40],[50],[54],[75]